Literature DB >> 21855053

De novo rates and selection of schizophrenia-associated copy number variants.

Elliott Rees1, Valentina Moskvina, Michael J Owen, Michael C O'Donovan, George Kirov.   

Abstract

BACKGROUND: At least 10 large and rare recurrent DNA copy number variants (CNVs) have been identified as risk factors for schizophrenia and other neurodevelopmental disorders. Because such conditions are associated with reduced fecundity, these pathogenic CNVs should be filtered out from the population by selection and must be replenished by de novo events.
METHODS: To estimate the mutation rate (μ) for these CNVs and the selection pressure (s) against them, we first conducted a literature review on the rate of each of these CNVs in the population and the rate of their de novo occurrence. In each generation, the number of CNVs lost because of reduced fertility must be replenished by the same number of de novo CNVs. Therefore, the observed ratio of de novo versus all (inherited + de novo) CNVs approximates the selection coefficient (s) of that CNV. The mutation rate approximates to μ = s × q, where q is the frequency of the CNV in the population.
RESULTS: High selection pressure operates at all these loci (s = .12 - .88), suggesting that following de novo occurrence, each of these CNVs persists in the population in only a few generations. The mutation rate for each CNV is high, affecting between 1:3500 and 1:30,000 individuals. The rarest CNVs have the highest selection coefficients.
CONCLUSIONS: The CNVs that increase risk to develop schizophrenia are caused by recent de novo mutations and are under strong selection pressure. They persist in the population because of high mutation rates. 2011 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21855053     DOI: 10.1016/j.biopsych.2011.07.011

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  37 in total

1.  De novo mutation in schizophrenia.

Authors:  Elliott Rees; George Kirov; Michael C O'Donovan; Michael J Owen
Journal:  Schizophr Bull       Date:  2012-03-26       Impact factor: 9.306

2.  Ohnologs are overrepresented in pathogenic copy number mutations.

Authors:  Aoife McLysaght; Takashi Makino; Hannah M Grayton; Maria Tropeano; Kevin J Mitchell; Evangelos Vassos; David A Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-24       Impact factor: 11.205

Review 3.  NDE1 and NDEL1 from genes to (mal)functions: parallel but distinct roles impacting on neurodevelopmental disorders and psychiatric illness.

Authors:  Nicholas J Bradshaw; Mirian A F Hayashi
Journal:  Cell Mol Life Sci       Date:  2016-10-14       Impact factor: 9.261

Review 4.  Genetics of schizophrenia from a clinicial perspective.

Authors:  Prachi Kukshal; B K Thelma; Vishwajit L Nimgaonkar; Smita N Deshpande
Journal:  Int Rev Psychiatry       Date:  2012-10

Review 5.  Positive Traits in the Bipolar Spectrum: The Space between Madness and Genius.

Authors:  Tiffany A Greenwood
Journal:  Mol Neuropsychiatry       Date:  2016-12-09

6.  Phenotypic spectrum and genotype-phenotype correlations of NRXN1 exon deletions.

Authors:  Christian P Schaaf; Philip M Boone; Srirangan Sampath; Charles Williams; Patricia I Bader; Jennifer M Mueller; Oleg A Shchelochkov; Chester W Brown; Heather P Crawford; James A Phalen; Nicole R Tartaglia; Patricia Evans; William M Campbell; Anne Chun-Hui Tsai; Lea Parsley; Stephanie W Grayson; Angela Scheuerle; Carol D Luzzi; Sandra K Thomas; Patricia A Eng; Sung-Hae L Kang; Ankita Patel; Pawel Stankiewicz; Sau W Cheung
Journal:  Eur J Hum Genet       Date:  2012-05-23       Impact factor: 4.246

7.  Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family study.

Authors:  Gregory Light; Tiffany A Greenwood; Neal R Swerdlow; Monica E Calkins; Robert Freedman; Michael F Green; Raquel E Gur; Ruben C Gur; Laura C Lazzeroni; Keith H Nuechterlein; Ann Olincy; Allen D Radant; Larry J Seidman; Larry J Siever; Jeremy M Silverman; Joyce Sprock; William S Stone; Catherine A Sugar; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; David L Braff
Journal:  Schizophr Bull       Date:  2014-06-05       Impact factor: 9.306

8.  Genetic modifiers and subtypes in schizophrenia: investigations of age at onset, severity, sex and family history.

Authors:  Sarah E Bergen; Colm T O'Dushlaine; Phil H Lee; Ayman H Fanous; Douglas M Ruderfer; Stephan Ripke; Patrick F Sullivan; Jordan W Smoller; Shaun M Purcell; Aiden Corvin
Journal:  Schizophr Res       Date:  2014-02-26       Impact factor: 4.939

9.  Implication of a rare deletion at distal 16p11.2 in schizophrenia.

Authors:  Saurav Guha; Elliott Rees; Ariel Darvasi; Dobril Ivanov; Masashi Ikeda; Sarah E Bergen; Patrik K Magnusson; Paul Cormican; Derek Morris; Michael Gill; Sven Cichon; Jeffrey A Rosenfeld; Annette Lee; Peter K Gregersen; John M Kane; Anil K Malhotra; Marcella Rietschel; Markus M Nöthen; Franziska Degenhardt; Lutz Priebe; René Breuer; Jana Strohmaier; Douglas M Ruderfer; Jennifer L Moran; Kimberly D Chambert; Alan R Sanders; Jianxin Shi; Kenneth Kendler; Brien Riley; Tony O'Neill; Dermot Walsh; Dheeraj Malhotra; Aiden Corvin; Shaun Purcell; Pamela Sklar; Nakao Iwata; Christina M Hultman; Patrick F Sullivan; Jonathan Sebat; Shane McCarthy; Pablo V Gejman; Douglas F Levinson; Michael J Owen; Michael C O'Donovan; Todd Lencz; George Kirov
Journal:  JAMA Psychiatry       Date:  2013-03       Impact factor: 21.596

10.  DNA methylation signatures of peripheral leukocytes in schizophrenia.

Authors:  Makoto Kinoshita; Shusuke Numata; Atsushi Tajima; Shinji Shimodera; Shinji Ono; Akira Imamura; Jun-ichi Iga; Shinya Watanabe; Kumiko Kikuchi; Hiroko Kubo; Masahito Nakataki; Satsuki Sumitani; Issei Imoto; Yuji Okazaki; Tetsuro Ohmori
Journal:  Neuromolecular Med       Date:  2012-09-09       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.